Earl H. Freimer
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 6
- Co-authors
- John B. ZabriskieRebecca C. LancefieldMaclyn McCartyRichard M. KrauseRoberta RaederDavid SenitzerBruce S. RibnerPaul F. Lehmann
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)The American Journal of Medicine (5 papers)The Journal of Experimental Medicine (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Earl H. Freimer
30 papers receiving 680 citations
Peers
Comparison fields: 5 of 82
- Molecular Medicine 91
- Applied Microbiology and Biotechnology 28
- Public Health, Environmental and Occupational Health 367
- Infectious Diseases 167
- Pharmacology 136
Countries citing papers authored by Earl H. Freimer
This map shows the geographic impact of Earl H. Freimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Earl H. Freimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Earl H. Freimer more than expected).
Fields of papers citing papers by Earl H. Freimer
This network shows the impact of papers produced by Earl H. Freimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Earl H. Freimer. The network helps show where Earl H. Freimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Earl H. Freimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 0 | |
| 2 | 1992 | 3 | |
| 3 | 1988 | 14 | |
| 4 | 1985 | 3 | |
| 5 | 1985 | 12 | |
| 6 | 1984 | 24 | |
| 7 | 1984 | 16 | |
| 8 | 1983 | 13 | |
| 9 | 1983 | 7 | |
| 10 | 1983 | 25 | |
| 11 | 1983 | 39 | |
| 12 | 1979 | 1 | |
| 13 | 1978 | 2 | |
| 14 | 1978 | 4 | |
| 15 | 1973 | 27 | |
| 16 | 1967 | 34 | |
| 17 | 1966 | 209 | |
| 18 | 1965 | 4 | |
| 19 | 1963 | 68 | |
| 20 | 1959 | 96 |
About Earl H. Freimer
Earl H. Freimer is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Endocrinology and Infectious Diseases, having authored 31 papers that have together received 860 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Streptococcal Infections and Treatments (8 papers), Antibiotic Resistance in Bacteria (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Neonatal and Maternal Infections (4 papers), Pneumonia and Respiratory Infections (3 papers), Immune Cell Function and Interaction (3 papers) and Infective Endocarditis Diagnosis and Management (3 papers). The work is most often cited by research in Molecular Medicine (91 citations), Applied Microbiology and Biotechnology (28 citations), Public Health, Environmental and Occupational Health (367 citations), Infectious Diseases (167 citations) and Pharmacology (136 citations). Earl H. Freimer has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include John B. Zabriskie, Rebecca C. Lancefield, Maclyn McCarty, Richard M. Krause, Roberta Raeder, David Senitzer, Bruce S. Ribner, Paul F. Lehmann, Haig Donabedian and Pitambar Somani. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The American Journal of Medicine, The Journal of Experimental Medicine, Journal of Antimicrobial Chemotherapy and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.